Repeat Dosing of Psilocybin in Migraine Headache
What is the purpose of this trial?
In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.
- Ages21 years - 65 years
- Trial withWallace Research Foundation
- Start Date01/01/2021
- End Date07/15/2022
- Last Updated04/05/2022
- Study HIC#2000026974